VTRS
$VTRS
Viatris Inc.
Global pharmaceutical company formed from Mylan and Pfizer Upjohn merger making generic and branded drugs.
Healthcare$13.50
-0.24 (-1.75%)
Day Range$13.12 - $13.88
Prev Close$13.74
Analyst Rating
Strong Buy
12 Buy / 5 Hold / 1 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
VTRS: Viatris Outlook, Valuation vs Catalysts
Viatris ($VTRS) shows renewed analyst interest and a dividend yield near 3.7%, but underlying profitability remains weak. This report weighs valuation, recent beats and rollout catalysts against execution and margin risks.
Mar 16, 2026